These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28212174)

  • 1. Categorizing and assessing negative symptoms.
    Bucci P; Galderisi S
    Curr Opin Psychiatry; 2017 May; 30(3):201-208. PubMed ID: 28212174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
    Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
    Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
    Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
    Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative symptoms of schizophrenia: new developments and unanswered research questions.
    Galderisi S; Mucci A; Buchanan RW; Arango C
    Lancet Psychiatry; 2018 Aug; 5(8):664-677. PubMed ID: 29602739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinic of apathy in schizophrenia: a critical review of the issue].
    Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
    Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How far to go in deconstructing negative symptoms? Behavioural and neural level evidence for the amotivation domain.
    Kaliuzhna M; Kirschner M; Carruzzo F; Hartmann-Riemer MN; Bischof M; Seifritz E; Tobler PN; Kaiser S
    Schizophr Res; 2021 Oct; 236():41-47. PubMed ID: 34390980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing concepts in negative symptoms: primary vs secondary and apathy vs expression.
    Kirkpatrick B
    J Clin Psychiatry; 2014; 75 Suppl 1():3-7. PubMed ID: 24581452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders.
    Foussias G; Agid O; Fervaha G; Remington G
    Eur Neuropsychopharmacol; 2014 May; 24(5):693-709. PubMed ID: 24275699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Negative symptoms in schizophrenia: psychotherapeutic approaches].
    Azorin JM; Adida M; Belzeaux R; Pringuey D; Micoulaud Franchi JA; Simon N; Cermolacce M; Kaladjian A; Fakra E
    Encephale; 2015 Dec; 41(6 Suppl 1):6S57-60. PubMed ID: 26776394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of the concept of apathy: the need for a multifactorial approach in schizophrenia].
    Del-Monte J; Capdevielle D; Gély-Nargeot MC; Yazbek H; Pupier F; Boulenger JP; Raffard S
    Encephale; 2013 May; 39 Suppl 1():S57-63. PubMed ID: 23351930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.
    Strauss GP; Horan WP; Kirkpatrick B; Fischer BA; Keller WR; Miski P; Buchanan RW; Green MF; Carpenter WT
    J Psychiatr Res; 2013 Jun; 47(6):783-90. PubMed ID: 23453820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome.
    Galderisi S; Bucci P; Mucci A; Kirkpatrick B; Pini S; Rossi A; Vita A; Maj M
    Schizophr Res; 2013 Jun; 147(1):157-162. PubMed ID: 23608244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construct validity of negative symptoms: an empirical and conceptual review.
    Earnst KS; Kring AM
    Clin Psychol Rev; 1997; 17(2):167-89. PubMed ID: 9140714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts.
    Liemburg E; Castelein S; Stewart R; van der Gaag M; Aleman A; Knegtering H;
    J Psychiatr Res; 2013 Jun; 47(6):718-25. PubMed ID: 23472837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Negative Symptoms in Schizophrenia - an Overview].
    Klaus F; Kaiser S; Kirschner M
    Ther Umsch; 2018 Jun; 75(1):51-56. PubMed ID: 29909762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Scale for assessing negative symptoms in schizophrenia: A systematic review].
    Mach C; Dollfus S
    Encephale; 2016 Apr; 42(2):165-71. PubMed ID: 26923997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amotivation and functional outcomes in early schizophrenia.
    Fervaha G; Foussias G; Agid O; Remington G
    Psychiatry Res; 2013 Dec; 210(2):665-8. PubMed ID: 23911005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive Emotions Program for Schizophrenia (PEPS): a pilot intervention to reduce anhedonia and apathy.
    Favrod J; Nguyen A; Fankhauser C; Ismailaj A; Hasler JD; Ringuet A; Rexhaj S; Bonsack C
    BMC Psychiatry; 2015 Sep; 15():231. PubMed ID: 26419356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia.
    Fervaha G; Foussias G; Agid O; Remington G
    Acta Psychiatr Scand; 2014 Oct; 130(4):290-9. PubMed ID: 24850369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating negative-symptom-like behavioural changes in developmental models of schizophrenia.
    Moser P
    Eur Neuropsychopharmacol; 2014 May; 24(5):774-87. PubMed ID: 24332891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.